Tricuspid valve replacement with a fresh antibiotic preserved tricuspid homograft.
Prosthetic replacement of valves in children is limited by size constraints of the prosthesis and lack of growth potential. In specific situations like infective endocarditis, valve preservation is near impossible and in such instances alternatives are hard to get. Furthermore, in the tricuspid position the long-term results of both mechanical and bioprosthesis are not optimal. We used an innovative method in a small boy with tricuspid valve endocarditis by using a tricuspid homograft in the tricuspid position.
Vaidyanathan
Karthik
K
Department of Cardiac Surgery, Frontier Lifeline, Dr. KM Cherian Heart Foundation, R 30 C Ambattur Industrial Estate Road, Mogappair, Chennai-600101, India. rkvdoc@rediffmail.com
Agarwal
Ravi
R
Johari
Raghav
R
Cherian
Kotturathu Mammen
KM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001705:Bioprosthesis; D002675:Child, Preschool; D004696:Endocarditis / Q000601:surgery*; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation*; D006801:Humans; D008297:Male; D014021:Tissue Preservation / Q000379:methods*; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D014261:Tricuspid Valve / Q000637:transplantation*
D000900:Anti-Bacterial Agents